ADAM28 and obesity disorder: Using siRNA technology, we also demonstrated that downregulation of ADAM28 resulted in a lack of weight gain, promotion of insulin sensitivity/glucose tolerance and decreased liver TNF-α levels in our diet-induced obesity mouse model as well as improved kidney function, and reduced liver injury .